|
Mar 18 ,2021
Gain Therapeutics Raises $40M in IPO to Advance Rare Disease Pipeline
|
|
Mar 18 ,2021
Lysosomal storage disorder biotech Gain Therapeutics prices IPO at $11 midpoint
|
|
Feb 02 ,2021
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
|
|
Sep 28 ,2020
Treating lysosomal storage disorders: Gain and Sumitomo Dainippon enter partnership
|
|
Sep 10 ,2020
Gain Therapeutics Inc. signs a collaboration with Sumitomo Dainippon Pharma Co. Ltd.
|
|
Jul 21 ,2020
Gain Therapeutics, Inc. Announces Close of $10 Million Series B Financing
|
|
Feb 10 ,2020
Gain Therapeutics finalizing animal proof-of-concept study in Parkinson's Disease
|